Phototoxicity Test of Dapsone Gel in Healthy Volunteers

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02108483

Enrollment

Registered

2014-04-09

Start date

2014-04-30

Completion date

2014-05-31

Last updated

2018-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

This study will evaluate the potential of dapsone gel and its vehicle to cause a phototoxic reaction following irradiation of the skin under controlled conditions.

Interventions

DRUGdapsone gel

Patches containing dapsone gel will be applied to the skin.

DRUGdapsone gel vehicle

Patches containing dapsone gel vehicle will be applied to the skin.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

-Healthy adults.

Exclusion criteria

* Skin diseases, excessive hair, tattoos, pigmentation, scars or moles that could interfere with patch application * Sensitivity to adhesive bandages or tape.

Design outcomes

Primary

Measure	Time frame
Phototoxicity Irritation Potential Using a Visual Scale	4 Days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026